2013-09-06 10:14:01 -
Biofrontera AG /
Biofrontera AG: Biofrontera announces brokerage agreement and research coverage
. Ad hoc announcement according to § 15 WpHG. Processed and transmitted by Thomson Reuters
The issuer is solely responsible for the content of this announcement.
Leverkusen, Germany, 6 September 2013 - Biofrontera AG (B8F) announces today
that it is now working with with the London based investment bank finnCap
regarding the brokerage of Biofrontera shares. FinnCap's renowned life science
analyst Dr. Keith Redpath has initiated coverage of Biofrontera, and will follow
the company in the future.
FinnCap is an independent UK investment house, with an excellent track record in
the financing of small and medium-sized companies. Extending the investor
relations activities towards institutional investors in London and the
initiation of research coverage by finnCap is
a consequent step towards the
internationalization of Biofrontera AG.
For further information please contact:
Anke zur Mühlen
+ 49 (0) 214 87632 22
+ 49 (0) 214 87632 90
Hemmelrather Weg 201
D- 51377 Leverkusen, Germany
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Biofrontera AG via Thomson Reuters ONE